Correlation Between Dermata Therapeutics and Intracellular
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Intracellular Th, you can compare the effects of market volatilities on Dermata Therapeutics and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Intracellular.
Diversification Opportunities for Dermata Therapeutics and Intracellular
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dermata and Intracellular is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Intracellular go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Intracellular
Given the investment horizon of 90 days Dermata Therapeutics is expected to under-perform the Intracellular. In addition to that, Dermata Therapeutics is 4.29 times more volatile than Intracellular Th. It trades about -0.03 of its total potential returns per unit of risk. Intracellular Th is currently generating about 0.05 per unit of volatility. If you would invest 5,425 in Intracellular Th on August 24, 2024 and sell it today you would earn a total of 3,120 from holding Intracellular Th or generate 57.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Dermata Therapeutics vs. Intracellular Th
Performance |
| Timeline |
| Dermata Therapeutics |
| Intracellular Th |
Dermata Therapeutics and Intracellular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and Intracellular
The main advantage of trading using opposite Dermata Therapeutics and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.| Dermata Therapeutics vs. ZyVersa Therapeutics | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp |
| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |